American Well (AMWL) Stock
Telehealth platform connecting patients doctors and health systems. Here's the price, business snapshot, and what's worth knowing about American Well in October 2026.
American Well Corporation (AMWL) is a US-based telehealth technology company that supplies a digital platform linking patients, clinicians and payers. The firm licences software to health systems, offers a consumer telehealth service and provides integration and professional services. Investors should know Amwell sits squarely within the structural trend towards virtual care, but it competes in a crowded market and has historically reported operating losses and cash burn. With a market capitalisation around $90.45m, AMWL is a small-cap, higher-risk equity where liquidity and capital needs are relevant considerations. Key potential upside drivers include wider adoption of virtual consultations, enterprise contracts and margin improvement as scale increases. Primary risks include intense competition, changing reimbursement or regulatory frameworks, execution on commercial contracts and the possibility of further equity dilution. This is educational information only, not personalised advice; values can rise and fall and returns are not guaranteed.
American Well (AMWL) Stock Forecast
Analyst price target, next 12 months
$24.09
+94.5% vs today's $12.39
Price range over the last 12 months
Close to its 12-month high
Analysts covering American Well have a consensus 12-month target of $24.09, above the current price of $12.39.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 25 May 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding American Well's stock with a target price of $24.09, indicating potential growth.
Financial Health
American Well Corp is performing well in revenue and cash flow, indicating strong operational efficiency.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Rising telehealth adoption
Virtual care demand has grown and could support Amwell’s addressable market, though sustained uptake depends on reimbursement and provider integration.
Partnership-led reach
Partnerships with health systems, insurers and tech platforms can broaden distribution, but contract execution and retention are crucial for long-term value.
Profitability and cash
Margin expansion and cash management are key to upside; conversely, ongoing losses or the need for additional funding would increase investor risk.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
